Pharmaceutical company Boehringer Ingelheim has mandated STRABAG Property and Facility Services with the technical facility management of six office and administrative buildings. The properties are distributed equally across the corporate locations in Ingelheim am Rhein and Biberach an der Riß. In total, the managed portfolio covers a gross floor area of more than 100,000 square metres.
Comprehensive scope of services and continuous operational reliability
The contractually agreed tasks cover almost the entire spectrum of technical facility management. To ensure uninterrupted operation of the demanding administrative sites, a 24/7 on-call service seven days a week is integrated, among other measures.
Alongside traditional maintenance and technical operational management, STRABAG PFS is supporting the research-driven pharmaceutical manufacturer with decarbonisation and operational energy management. The objective is energy-efficient, forward-looking management of the existing building stock at both locations.
Cross-site management in a regulated environment
The coordination and management of the contractual services is carried out across locations via the central key account organisation of STRABAG PFS. The collaboration is structured on a long-term partnership basis to meet the rigorous demands of the research-intensive client.
- —Three administrative buildings at the headquarters in Ingelheim am Rhein
- —Three office complexes at the research and development site in Biberach an der Riß
- —More than 100,000 square metres of total managed area
- —Integration of energy management, decarbonisation and round-the-clock technical service
Boehringer Ingelheim has been family-owned since its foundation in 1885 and ranks among the world's top 20 pharmaceutical companies. In the 2025 financial year, the group generated net sales of 27.8 billion euros. For STRABAG PFS, the new contract strengthens its market presence in the commercial property segment linked to research and development, while further expanding its service portfolio in the regulated life sciences sector.
